bioRASI hires new vice president of business development

The company said that it has significantly expanded its worldwide operational infrastructure and is now adding a corresponding upgrade to its business development functions. Mr Thompson will lead these global efforts.

Prior to joining bioRASI, MrThompson served as the vice president of business development for Bio Pharma Services as well as the head of business development for Veeda Clinical Research.

Boris Reznik, chairman of bioRASI, said: “Over three decades, Gary has played an integral role in shaping the biotech and pharma industry. In every area he has proved himself a very strong leader; likeable, knowledgeable and well trusted by the industry. In conjunction with the opening of several new offices around the world, Gary will lead our efforts, providing optimal solutions to our clients’ clinical development programs.”